TG Therapeutics, Inc. (TGTX): Price and Financial Metrics
TGTX Price/Volume Stats
| Current price | $14.36 | 52-week high | $35.67 |
| Prev. close | $13.82 | 52-week low | $6.46 |
| Day low | $13.85 | Volume | 930,820 |
| Day high | $14.53 | Avg. volume | 4,159,263 |
| 50-day MA | $15.14 | Dividend yield | N/A |
| 200-day MA | $13.81 | Market Cap | 2.22B |
TGTX Stock Price Chart Interactive Chart >
TG Therapeutics, Inc. (TGTX) Company Bio
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company was founded in 1993 and is based in New York, New York.
Latest TGTX News From Around the Web
Below are the latest news stories about TG THERAPEUTICS INC that investors may wish to consider to help them evaluate TGTX as an investment opportunity.
11 Most Promising Biotech Stocks to Buy According to AnalystsIn this article, we will take a look at the 11 most promising biotech stocks to buy according to analysts. To skip our analysis of the recent trends, and market activity, you can go directly to see the 5 Most Promising Biotech Stocks to Buy According to Analysts. The biotech industry is making a resurgence […] |
TG Therapeutics Stock Clears Technical Benchmark, Hitting 90-Plus RS RatingTG Therapeutics stock saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, rising from 87 to 93. When looking for the best stocks to buy and watch, be sure to pay attention to relative price strength. |
TG Therapeutics (NASDAQ:TGTX) grows 9.1% this week, taking five-year gains to 170%When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can... |
TG Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx ConferenceFireside chat scheduled for Wednesday, November 29, 2023, at 2:10 PM ETNEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the 6th Annual Evercore ISI HealthCONx Conference, being held at the Kimpton EPIC Hotel, in Miami, Florida on November 28 - 30, 2023. The fireside chat is scheduled to take place on Wednesday, November 29, 2023, at 2:10 PM ET. A live web |
Does TG Therapeutics (TGTX) Have the Potential to Rally 127.76% as Wall Street Analysts Expect?The average of price targets set by Wall Street analysts indicates a potential upside of 127.8% in TG Therapeutics (TGTX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. |
TGTX Price Returns
| 1-mo | -6.33% |
| 3-mo | -4.71% |
| 6-mo | 112.74% |
| 1-year | -34.43% |
| 3-year | -66.46% |
| 5-year | 83.40% |
| YTD | -15.93% |
| 2023 | 44.38% |
| 2022 | -37.74% |
| 2021 | -63.48% |
| 2020 | 368.65% |
| 2019 | 170.73% |
Continue Researching TGTX
Want to see what other sources are saying about Tg Therapeutics Inc's financials and stock price? Try the links below:Tg Therapeutics Inc (TGTX) Stock Price | Nasdaq
Tg Therapeutics Inc (TGTX) Stock Quote, History and News - Yahoo Finance
Tg Therapeutics Inc (TGTX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...